HY-141622

SDZ 224-015

SDZ 224-015 is an orally active inhibitor of the interleukin-1 beta (IL-1β) converting enzyme and caspase-1. SDZ 224-015 possesses anti-COVID-19 activity, targeting Mpro (IC50 of 30 nM)[1][2].

2922.19 €

MBS5785041-10mg

SDZ 224-015

975.5 €

MBS5785041-25mg

SDZ 224-015

2186.75 €

A8890-10

HTH-01-015

PI3K/Akt/mTOR Signaling|AMPK

416.6 €

A8890-100

HTH-01-015

PI3K/Akt/mTOR Signaling|AMPK

701 €

A8890-200

HTH-01-015

HTH-01-015 is a highly specific inhibitor of NUAK1 with IC50 value of 100 nM 1.HTH-01-015 showed extreme selectivity. It only inhibited the NUAK1 (NUAK family SNF1-like kinase-1) isoform of NUAK kinases and showed no significant inhibition of 139 other tested kinases.

1545.2 €